Aguirre Sergio D, Ali M Monsur, Kanda Pushpinder, Li Yingfu
Department of Biochemistry and Biomedical Sciences, McMaster University, Canada.
J Vis Exp. 2012 May 28(63):3961. doi: 10.3791/3961.
Outbreaks linked to food-borne and hospital-acquired pathogens account for millions of deaths and hospitalizations as well as colossal economic losses each and every year. Prevention of such outbreaks and minimization of the impact of an ongoing epidemic place an ever-increasing demand for analytical methods that can accurately identify culprit pathogens at the earliest stage. Although there is a large array of effective methods for pathogen detection, none of them can satisfy all the following five premier requirements embodied for an ideal detection method: high specificity (detecting only the bacterium of interest), high sensitivity (capable of detecting as low as a single live bacterial cell), short time-to-results (minutes to hours), great operational simplicity (no need for lengthy sampling procedures and the use of specialized equipment), and cost effectiveness. For example, classical microbiological methods are highly specific but require a long time (days to weeks) to acquire a definitive result.(1) PCR- and antibody-based techniques offer shorter waiting times (hours to days), but they require the use of expensive reagents and/or sophisticated equipment.(2-4) Consequently, there is still a great demand for scientific research towards developing innovative bacterial detection methods that offer improved characteristics in one or more of the aforementioned requirements. Our laboratory is interested in examining the potential of DNAzymes as a novel class of molecular probes for biosensing applications including bacterial detection.(5) DNAzymes (also known as deoxyribozymes or DNA enzymes) are man-made single-stranded DNA molecules with the capability of catalyzing chemical reactions.(6-8) These molecules can be isolated from a vast random-sequence DNA pool (which contains as many as 10(16) individual sequences) by a process known as "in vitro selection" or "SELEX" (systematic evolution of ligands by exponential enrichment).(9-16) These special DNA molecules have been widely examined in recent years as molecular tools for biosensing applications.(6-8) Our laboratory has established in vitro selection procedures for isolating RNA-cleaving fluorescent DNAzymes (RFDs; Fig. 1) and investigated the use of RFDs as analytical tools.(17-29) RFDs catalyze the cleavage of a DNA-RNA chimeric substrate at a single ribonucleotide junction (R) that is flanked by a fluorophore (F) and a quencher (Q). The close proximity of F and Q renders the uncleaved substrate minimal fluorescence. However, the cleavage event leads to the separation of F and Q, which is accompanied by significant increase of fluorescence intensity. More recently, we developed a method of isolating RFDs for bacterial detection.(5) These special RFDs were isolated to "light up" in the presence of the crude extracellular mixture (CEM) left behind by a specific type of bacteria in their environment or in the media they are cultured (Fig. 1). The use of crude mixture circumvents the tedious process of purifying and identifying a suitable target from the microbe of interest for biosensor development (which could take months or years to complete). The use of extracellular targets means the assaying procedure is simple because there is no need for steps to obtain intracellular targets. Using the above approach, we derived an RFD that cleaves its substrate (FS1; Fig. 2A) only in the presence of the CEM produced by E. coli (CEM-EC).(5) This E. coli-sensing RFD, named RFD-EC1 (Fig. 2A), was found to be strictly responsive to CEM-EC but nonresponsive to CEMs from a host of other bacteria (Fig. 3). Here we present the key experimental procedures for setting up E. coli detection assays using RFD-EC1 and representative results.
每年,与食源性病原体和医院获得性病原体有关的疫情导致数百万人死亡和住院,造成了巨大的经济损失。预防此类疫情并尽量减少持续流行疫情的影响,对能够在最早阶段准确识别致病病原体的分析方法的需求日益增加。尽管有大量有效的病原体检测方法,但没有一种能满足理想检测方法所具备的以下五个首要要求:高特异性(仅检测目标细菌)、高灵敏度(能够检测低至单个活细菌细胞)、短出结果时间(几分钟到几小时)、操作极其简便(无需冗长的采样程序和使用专门设备)以及成本效益。例如,经典微生物学方法具有高度特异性,但需要很长时间(数天到数周)才能获得明确结果。(1)基于聚合酶链反应(PCR)和抗体的技术等待时间较短(数小时到数天),但需要使用昂贵的试剂和/或精密设备。(2 - 4)因此,仍然迫切需要开展科研工作,以开发在上述一项或多项要求方面具有改进特性的创新细菌检测方法。我们实验室有兴趣研究脱氧核酶作为一类新型分子探针在包括细菌检测在内的生物传感应用中的潜力。(5)脱氧核酶(也称为脱氧核糖酶或DNA酶)是具有催化化学反应能力的人工合成单链DNA分子。(6 - 8)这些分子可以通过一种称为“体外筛选”或“指数富集配体系统进化技术(SELEX)”的过程从庞大的随机序列DNA库(其中包含多达10^16个个体序列)中分离出来。(9 - 16)近年来,这些特殊的DNA分子作为生物传感应用的分子工具受到了广泛研究。(6 - 8)我们实验室已经建立了分离切割RNA的荧光脱氧核酶(RFDs;图1)的体外筛选程序,并研究了RFDs作为分析工具的用途。(17 - 29)RFDs在单个核糖核苷酸连接处(R)催化DNA - RNA嵌合底物的切割,该连接处两侧分别是荧光团(F)和猝灭剂(Q)。F和Q靠得很近,使得未切割的底物荧光很弱。然而,切割事件导致F和Q分离,同时荧光强度显著增加。最近,我们开发了一种分离用于细菌检测的RFDs的方法。(5)这些特殊的RFDs被分离出来,以便在特定类型细菌在其环境中或在它们所培养的培养基中留下的粗细胞外混合物(CEM)存在时“发光”(图1)。使用粗混合物避免了为生物传感器开发从目标微生物中纯化和鉴定合适靶标的繁琐过程(这可能需要数月或数年才能完成)。使用细胞外靶标意味着检测程序很简单,因为无需获取细胞内靶标的步骤。使用上述方法,我们获得了一种仅在大肠杆菌产生的CEM(CEM - EC)存在时切割其底物(FS1;图2A)的RFD。(5)这种检测大肠杆菌的RFD,命名为RFD - EC1(图2A),被发现对CEM - EC有严格响应,但对许多其他细菌的CEM无响应(图3)。在此,我们展示了使用RFD - EC1建立大肠杆菌检测分析的关键实验步骤和代表性结果。